中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 7
Jul.  2011
Turn off MathJax
Article Contents

Relationship between serum visfatin and serum adiponectin level and the pathology of nonalcoholic fatty liver disease

  • Published Date: 2011-07-20
  • Objective To explore the relationship between serum visfatin and adiponectin levels and the pathology of NAFLD.Methods 54 patients were divided into 3 groups according to the pathology, including control group, simple steatosis group, and nonalcoholic steatohepatitis group.Serum visfatin and adiponectin levels were measured by enzymelinked immunosorbent assay.Results Among the 54 patients, control group includes 23 cases;simple steatosis group comprises of 11 cases;while nonalcoholic steatohepatitis group contains 20 cases.The level of serum visfatin of NASH group is lower than that of control group and simple steatosis group.Moreover, the change of serum adiponectin of NASH is as same as serum visfatin.Conclusion In NAFLD patients, the more severe the changes of steatosis and inflammation of the histopathology in liver, the lower levels of visfatin and adiponectin in plasma concentrations were showed.

     

  • loading
  • [1]Musso G, Gambino R, Cassader M.Non-alcoholic fatty liverdisease from pathogenesis to management:an update[J].Obes Rev, 2010, 11 (6) :430-445.
    [2]Kamada Y, Takehara T, Hayashi N.Adipocytokines and liverdisease[J].J Gastroenterol, 2008, 43 (11) :811-822.
    [3]Low S, Chin MC, Ma S, et al.Rationale for redefining obesityin Asians[J].Ann Acad Med Singapore, 2009, 38 (1) :66-69.
    [4]中华医学会.非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志, 2006, 14 (3) :161-163.
    [5]沙卫红, 李瑜元.2009年美国消化疾病会议周概况[J].中华消化杂志, 2009, 29 (8) :547-549.
    [6]Fierbinteanu-Braticevici C, Dina I, Petrisor A, et al.Noninvasiveinvestigations for non alcoholic fatty liver disease and liverfibrosis[J].World J Gastroenterol, 2010, 16 (38) :4784-4791.
    [7]Lewis JR, Mohanty SR.Nonalcoholic fatty liver disease:areview and update[J].Dig Dis Sci, 2010, 55 (3) :560-578.
    [8]Balsano C, Alisi A, Nobili V.Liver fibrosis and therapeuticstrategies:the goal for improving metabolism[J].Curr DrugTargets, 2009, 10 (6) :505-512.
    [9]Lonardo A, Carani C, Carulli N, et al.'Endocrine NAFLD'ahormonocentric perspective of nonalcoholic fatty liver diseasepathogenesis[J].J Hepatol, 2006, 44 (6) :1196-1207.
    [10]Fukuhara A, Matsuda M, Nishizawa M, et al.Visfatin:a proteinsecreted by visceral fat that mimics the effects of insulin[J].Science, 2005, 307 (5708) :426-430.
    [11]Targher G, Bertolini L, Rodella S, et al.Associations betweenplasma adiponectin concentrations and liver histologyin patients with nonalcoholic fatty liver disease[J].ClinEndocrinol (Oxf) , 2006, 64 (6) :679-683.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (2967) PDF downloads(987) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return